4//SEC Filing
Daruwala Paul 4
Accession 0001610618-22-000076
CIK 0001610618other
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 6:40 PM ET
Size
8.6 KB
Accession
0001610618-22-000076
Insider Transaction Report
Form 4
Daruwala Paul
Chief Medical Officer
Transactions
- Sale
Common Stock
2022-09-12$0.68/sh−16,199$11,095→ 221,099 total
Footnotes (1)
- [F1]Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units on September 10, 2022. These sales are mandated by the Reporting Person's election to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
Issuer
Cidara Therapeutics, Inc.
CIK 0001610618
Entity typeother
Related Parties
1- filerCIK 0001639144
Filing Metadata
- Form type
- 4
- Filed
- Sep 12, 8:00 PM ET
- Accepted
- Sep 13, 6:40 PM ET
- Size
- 8.6 KB